Back

Hyperhomocysteinemia and mitral valve calcification in rheumatic heart disease: insights from a novel multi-modality imaging approach

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Mitral stenosis and rheumatic heart disease Mitral Valve Stenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Songhao Jia

Beijing (China)

5 More presentations in this session

Presentation thumbnail
Association between white blood cell-based inflammatory markers and the severity of rheumatic mitral stenosis in a tertiary referral hospital in Indonesia
Doctor A. Laila (Bandung, ID)
Abstract Slides Video
Presentation thumbnail
Feasibility and midterm outcomes of mitral valve repair in rheumatic heart disease: a multicenter study with multimodal imaging insights
Doctor S. Jia (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Rheumatic heart disease prevalence in migrant populations in germany, a pilot study
Doctor M. Steinmaurer (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Percutaneous transvenous mitral commissurotomy: In hospital and intermediate term follow up outcome from a prosepctive registry
Doctor R. Partheeban (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Quality of surgical care for rheumatic heart disease patients: insights from the Netherlands Heart Registration
Miss L. De Wilde (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Mitral stenosis and rheumatic heart disease

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Feasibility and midterm outcomes of mitral valve repair in rheumatic heart disease: a multicenter study with multimodal imaging insights
thumbnail
Congress Session
Multivalve rheumatic heart disease: clinical challenges
thumbnail
Congress Presentation
Sudden, severe mitral regurgitation secondary to a ruptured chordae in a young patient with unknown rheumatic heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources